Show Notes
Nishi Vootukuru (@Nishi_Vootukuru) and Dr. Ezra Schwartz (@ezraschwartz10) interview Dr. William Shutze and Dr. Anahita Dua (@AnahitaDua) to discuss the Get a Pulse on PAD Campaign.
The Get a Pulse on PAD initiative (#PulseonPAD), launched in February, 2024, is a patient education and advocacy campaign designed to increase the understanding of peripheral artery disease's risk factors and potential symptoms.
Dr. Shutze is a vascular surgeon with Texas Vascular Associates in Dallas, Texas and the Secretary of the SVS. Dr. Shutze completed his medical studies at Baylor University after completing general surgery residency at University of Alabama in Birmingham. Dr. Shutze returned to Baylor to complete his vascular fellowship. Dr. Shutze is one of the Get a Pulse on PAD initiative's chairs and a leading expert in PAD. He has actively published in the field with over 100 abstracts and articles, with his most recent work focusing on prosthetics, and advocating for successful prosthetic referral after amputation.
Dr. Dua is a vascular surgeon at Mass General Hospital and associate professor at Harvard Medical School. At Mass General, she is the director of the Vascular Lab, co-director of the Peripheral Artery Disease Center and Limb Evaluation and Amputation Program (LEAPP), associate director of the Wound Care Center, director of the Lymphedema Center and director of clinical research for the division of vascular surgery. She serves as the Editor-in-Chief of Journal of Vascular Surgery-Vascular Insights. Dr. Dua completed her undergraduate medical studies at the Aberdeen University School of Medicine in Aberdeen, Scotland. She then completed her general surgery residency at the Medical College of Wisconsin and vascular fellowship at Stanford University Hospital. She holds multiple master's degrees including degrees in trauma sciences and business administration in healthcare management. She also completed certificate programs at the Massachusetts Institute of Technology in health economics and outcomes research as well as in drug and device development. Dr. Dua is a prolific researcher, researcher, and advocate, with much of her work centered on PAD. She furthers patient care not only through research but through her political work as Founder of the Healthcare for Action political action committee (PAC) and member of the SVS PAC Steering Committee.
Special thank you to Jacob Soucey (@JacobWSoucy)
Resources: https://www.secondscount.org/get-a-pulse-pad
Association of Black Cardiologists (ABC)
Society for Cardiovascular Angiography & Interventions (SCAI)
Society of Interventional Radiology (SIR)
CardioVascular Coalition (CVC)
Outpatient Endovascular and Interventional Society (OEIS)
https://vascular.org/advocacy/political-action-committee
https://evtoday.com/articles/2021-may/the-arc-act-fighting-amputation-via-legislation
CLariTI Study: Natural Progression of High-Risk Chronic Limb-Threatening Ischemia
Socioeconomic and hospital-related predictors of amputation for critical limb ischemia
ARC Act of Congress
Painkiller: TV Series
Congressman Payne
SAAAVE Act
Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.
More from Audible Bleeding
Audible Bleeding editor Wen Kawaji (@WenKawaji) is joined by Dr. Danielle Garcia, Dr. Robert Meyers, JVS editor Dr. Duncan (@ADuncanVasc), and JVS-VL editor Dr. Ruth Bush to discuss some of our favorite articles in the JVS family of journals.
Jacob Soucy (@JacobWSoucy) hosts an inside look at a timely and thought-provoking editorial published in The Vascular Specialist, the official news magazine of the Society for Vascular Surgery. In this episode, we explore the introduction of preference signaling to the integrated vascular surgery match through the lens of the editorial "This Signal Brings Noise." The discussion examines whether signaling addresses problems that exist within the vascular surgery match, how signals may influence interview selection, and the potential unintended consequences of introducing artificial scarcity into an already highly successful match process. Jacob speaks with Dr. Malachi G. Sheahan III about the motivation behind the piece, the problems preference signaling is intended to solve, how applicants and programs may approach the new system, and why signaling may turn the application process into a strategic game. They also discuss application review, virtual versus in-person interviews, the role of program reputation and mentorship in applicant decision-making, and what the vascular surgery community should watch as signaling is implemented for the first time.
Audible Bleeding Editor and vascular surgery fellow Sasank Kalipatnapu (@ksasank) is joined by James Martinson, a practicing general surgeon with an interest in vascular surgery, currently serving as the ship's surgeon for the USS John F. Kennedy aircraft carrier; JVS editor Dr. Audra Duncan (@ADuncanVasc); and JVS-CIT editor Dr. Matthew Smeds (@MattSmeds) to discuss two great articles in the JVS family of journals. Articles: Part 1: The association between multimorbidity and arteriovenous fistula creation outcomes (Wei and Woo)
Audible Bleeding Editor and vascular surgery fellow Richa Kalsi (@KalsiMD) is joined by James Martinson, practicing general surgeon with an interest in vascular surgery currently serving as the ship's surgeon for the USS Harry S Truman aircraft carrier and Langford Green (@langfordgreen_), research fellow at the Center for Vascular Research at the University of Maryland currently applying to medical school, JVS editor Dr. Audra Duncan (@ADuncanVasc), and JVS-VI editor Dr. Anahita Dua (@AnahitaDua) to discuss two great articles in the JVS family of journals. Articles: Part 1: Open bypass versus endovascular therapy in chronic limb-threatening ischemia patients with prior endovascular attempts (Hamouda & Malas)
Welcome back to the Audible Bleeding Series: Landmark Papers in Vascular Surgery. In this episode, Audible Bleeding editor John Culhane and co-host Dr. Jesse Columbo are joined by our guests, Dr. David Stone, Dr. Salvatore Scali, and Dr. Anders Wanhainen to unpack one of the longest-running debates in aortic surgery: when (and whether) to repair an abdominal aortic aneurysm. We'll start our episode with the open-repair era and the two trials that set the basis for the 5.5 cm threshold—UKSAT and ADAM—then move into the early EVAR years with PIVOTAL and CAESAR, which asked whether fixing smaller aneurysms with endovascular technology could do better. Finally, we'll look at how modern screening programs, improved medical therapy, and current guidelines have reshaped the practical decisions we make for these patients every day.